Latest Whitepapers

This case study highlights how a CDMO at risk of a facility shutdown solved severe supply disruption problems with the help of an experienced sourcing service.

This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.

For a smooth molecule journey from benchtop to clinic you need to make the most informed candidate selection and reduce the risk of failure and complications during development. Our BiacoreTM systems support informed decision-making during the lead candidate selection process. Its technology delivers valuable insights into developability such as manufacturability and safety.

This whitepaper highlights common challenges in gene therapy development and explores the latest analytical approaches available to combat workflow disruption.

Proteomics provides crucial insights into cell signaling and disease mechanisms for biomedical and clinical research. Nevertheless, traditional LC-MS/MS methods have limitations in sensitivity, reproducibility and scalability within proteomics applications.

This whitepaper explores the importance of data integrity in drug manufacturing workflows, so you stay up to date with the latest regulations.

This whitepaper explores how antibody-based affinity chromatography can reduce the number of process steps, improve yield and increase the purity of your biologic products.

Cell culture is essential for a variety of applications including disease modeling, drug discovery, cell-based manufacturing and genetic engineering.

Although there are initiatives to de-risk the drug development process, continually applying the same tools and approaches is unlikely to lead to innovative, first- or best-in-class targets and transformative progress.

Amidst the life science industry’s digital transformation, new and established companies have pioneered innovative ways to harness data and technology across the drug development lifecycle.